Cargando…
Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994619/ https://www.ncbi.nlm.nih.gov/pubmed/31982828 http://dx.doi.org/10.1016/j.ebiom.2019.12.004 |
| _version_ | 1783493230990458880 |
|---|---|
| author | Hickson, LaTonya J. Langhi Prata, Larissa G.P. Bobart, Shane A. Evans, Tamara K. Giorgadze, Nino Hashmi, Shahrukh K. Herrmann, Sandra M. Jensen, Michael D. Jia, Qingyi Jordan, Kyra L. Kellogg, Todd A. Khosla, Sundeep Koerber, Daniel M. Lagnado, Anthony B. Lawson, Donna K. LeBrasseur, Nathan K. Lerman, Lilach O. McDonald, Kathleen M. McKenzie, Travis J. Passos, João F. Pignolo, Robert J. Pirtskhalava, Tamar Saadiq, Ishran M. Schaefer, Kalli K. Textor, Stephen C. Victorelli, Stella G. Volkman, Tammie L. Xue, Ailing Wentworth, Mark A. Wissler Gerdes, Erin O. Allison, David B. Dickinson, Stephanie L. Ejima, Keisuke Atkinson, Elizabeth J. Lenburg, Marc Zhu, Yi Tchkonia, Tamara Kirkland, James L. |
| author_facet | Hickson, LaTonya J. Langhi Prata, Larissa G.P. Bobart, Shane A. Evans, Tamara K. Giorgadze, Nino Hashmi, Shahrukh K. Herrmann, Sandra M. Jensen, Michael D. Jia, Qingyi Jordan, Kyra L. Kellogg, Todd A. Khosla, Sundeep Koerber, Daniel M. Lagnado, Anthony B. Lawson, Donna K. LeBrasseur, Nathan K. Lerman, Lilach O. McDonald, Kathleen M. McKenzie, Travis J. Passos, João F. Pignolo, Robert J. Pirtskhalava, Tamar Saadiq, Ishran M. Schaefer, Kalli K. Textor, Stephen C. Victorelli, Stella G. Volkman, Tammie L. Xue, Ailing Wentworth, Mark A. Wissler Gerdes, Erin O. Allison, David B. Dickinson, Stephanie L. Ejima, Keisuke Atkinson, Elizabeth J. Lenburg, Marc Zhu, Yi Tchkonia, Tamara Kirkland, James L. |
| author_sort | Hickson, LaTonya J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6994619 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-69946192020-02-04 Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456 Hickson, LaTonya J. Langhi Prata, Larissa G.P. Bobart, Shane A. Evans, Tamara K. Giorgadze, Nino Hashmi, Shahrukh K. Herrmann, Sandra M. Jensen, Michael D. Jia, Qingyi Jordan, Kyra L. Kellogg, Todd A. Khosla, Sundeep Koerber, Daniel M. Lagnado, Anthony B. Lawson, Donna K. LeBrasseur, Nathan K. Lerman, Lilach O. McDonald, Kathleen M. McKenzie, Travis J. Passos, João F. Pignolo, Robert J. Pirtskhalava, Tamar Saadiq, Ishran M. Schaefer, Kalli K. Textor, Stephen C. Victorelli, Stella G. Volkman, Tammie L. Xue, Ailing Wentworth, Mark A. Wissler Gerdes, Erin O. Allison, David B. Dickinson, Stephanie L. Ejima, Keisuke Atkinson, Elizabeth J. Lenburg, Marc Zhu, Yi Tchkonia, Tamara Kirkland, James L. EBioMedicine Corrigendum Elsevier 2020-01-23 /pmc/articles/PMC6994619/ /pubmed/31982828 http://dx.doi.org/10.1016/j.ebiom.2019.12.004 Text en © 2019 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Corrigendum Hickson, LaTonya J. Langhi Prata, Larissa G.P. Bobart, Shane A. Evans, Tamara K. Giorgadze, Nino Hashmi, Shahrukh K. Herrmann, Sandra M. Jensen, Michael D. Jia, Qingyi Jordan, Kyra L. Kellogg, Todd A. Khosla, Sundeep Koerber, Daniel M. Lagnado, Anthony B. Lawson, Donna K. LeBrasseur, Nathan K. Lerman, Lilach O. McDonald, Kathleen M. McKenzie, Travis J. Passos, João F. Pignolo, Robert J. Pirtskhalava, Tamar Saadiq, Ishran M. Schaefer, Kalli K. Textor, Stephen C. Victorelli, Stella G. Volkman, Tammie L. Xue, Ailing Wentworth, Mark A. Wissler Gerdes, Erin O. Allison, David B. Dickinson, Stephanie L. Ejima, Keisuke Atkinson, Elizabeth J. Lenburg, Marc Zhu, Yi Tchkonia, Tamara Kirkland, James L. Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456 |
| title | Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456 |
| title_full | Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456 |
| title_fullStr | Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456 |
| title_full_unstemmed | Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456 |
| title_short | Corrigendum to ‘Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease’ EBioMedicine 47 (2019) 446–456 |
| title_sort | corrigendum to ‘senolytics decrease senescent cells in humans: preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease’ ebiomedicine 47 (2019) 446–456 |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994619/ https://www.ncbi.nlm.nih.gov/pubmed/31982828 http://dx.doi.org/10.1016/j.ebiom.2019.12.004 |
| work_keys_str_mv | AT hicksonlatonyaj corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT langhipratalarissagp corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT bobartshanea corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT evanstamarak corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT giorgadzenino corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT hashmishahrukhk corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT herrmannsandram corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT jensenmichaeld corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT jiaqingyi corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT jordankyral corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT kelloggtodda corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT khoslasundeep corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT koerberdanielm corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT lagnadoanthonyb corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT lawsondonnak corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT lebrasseurnathank corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT lermanlilacho corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT mcdonaldkathleenm corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT mckenzietravisj corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT passosjoaof corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT pignolorobertj corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT pirtskhalavatamar corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT saadiqishranm corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT schaeferkallik corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT textorstephenc corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT victorellistellag corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT volkmantammiel corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT xueailing corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT wentworthmarka corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT wisslergerdeserino corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT allisondavidb corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT dickinsonstephaniel corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT ejimakeisuke corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT atkinsonelizabethj corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT lenburgmarc corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT zhuyi corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT tchkoniatamara corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 AT kirklandjamesl corrigendumtosenolyticsdecreasesenescentcellsinhumanspreliminaryreportfromaclinicaltrialofdasatinibplusquercetininindividualswithdiabetickidneydiseaseebiomedicine472019446456 |